Upsher-Smith Launches Carbamazepine Extended-Release Tablets, USP

Sawai Receives Approvals for Four Generic Drugs with Eight Strengths

Upsher-Smith Launches Isotretinoin Capsules

Sawai Launches Eight Generic Drugs with 23 Strengths

Upsher-Smith and Rafarm Announce Launch of Moxifloxacin Ophthalmic Solution, USP 0.5%

Financial Summary for 1Q of FY2021

FY2021 Financial Results for the 1st Quarter

Allocation of Stock-Based Compensation Stock Options

Long-Term Vision for 2030 and Medium-Term Business Plan

Financial Summary for the Fiscal Year Ended March 31, 2021